What is a biosimilar?

Whether for cancer, rheumatism or Crohn's disease, more and more patients are receiving a biosimilar instead of the original biopharmaceutical. But what exactly is a biosimilar?

Read more

This is what biosimilars stand for!

same quality

more supply

less costs

Read more
We must not repeat the same mistake!

Peter Stenico, chairman of AG Pro Biosimilars, warns against automatic substitution in biosimilars: "We've seen what cost pressures do to generics: production migration and a supply that becomes more unstable."

Read more

Our topics

Here we have summarized how biosimilars save millions of euros, for which patient groups they are used - and which developments could jeopardize their success.

Read more
Biosimilars in der Onkologie

Biosimilars for more and more patients

For the past 15 years, biosimilars have been approved in an increasing number of indications. They have thus become an important weapon in the fight against serious diseases.

Read more

Discuss with us on Twitter

Important news and quick updates ca be found over on our Twitter. We look forward to lively discussions with you here. (in German)


Follow us on YouTube

On our YouTube channel you can find short films all about biosimilars – such as how one rheumatic patients’ life has changed since receiving treatment with biosimilars. Have a look!